BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6176101)

  • 1. Platelet-activating factor (PAF-acether): present status.
    Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):542-4. PubMed ID: 6176101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process?
    Mencia-Huerta JM; Ninio E; Roubin R; Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):556-8. PubMed ID: 7053072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
    Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
    J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of some structural analogs of platelet-activating factor (PAF-acether).
    Ténce M; Michel E; Coeffier E; Polonsky J; Godfroid JJ; Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):558-9. PubMed ID: 7340440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages.
    Ninio E; Mencia-Huerta JM; Heymans F; Benveniste J
    Biochim Biophys Acta; 1982 Jan; 710(1):23-31. PubMed ID: 7055592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
    Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
    Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.
    Prancan A; Lefort J; Barton M; Vargaftig BB
    Eur J Pharmacol; 1982 May; 80(1):29-35. PubMed ID: 7095003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
    Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
    Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of structural analogues of PAF-acether on platelet desensitization.
    Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
    Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
    Benveniste J; Chignard M; Le Couedic JP; Vargaftig BB
    Thromb Res; 1982 Mar; 25(5):375-85. PubMed ID: 6803388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-tissue interaction: role of platelet-activating factor (PAF-acether).
    Vargaftig BB; Chignard M; Lefort J; Benveniste J
    Agents Actions; 1980 Dec; 10(6):502-6. PubMed ID: 7270336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.
    Chignard M; Le Couedic JP; Coëffier E; Benveniste J
    Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?
    Benveniste J; Chignard M
    Circulation; 1985 Oct; 72(4):713-7. PubMed ID: 3928192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
    Camussi G; Tetta C; Segoloni G; Chiara Deregibus M; Bussolino F
    Agents Actions; 1981 Dec; 11(6-7):550-3. PubMed ID: 7041569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.
    Darius H; Lefer DJ; Smith JB; Lefer AM
    Science; 1986 Apr; 232(4746):58-60. PubMed ID: 3082008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.